Sleeptalking! Sleepwalking! Side Effects of Montelukast
Open Access
- 5 September 2013
- journal article
- case report
- Published by Hindawi Limited in Case Reports in Pulmonology
- Vol. 2013, 1-3
- https://doi.org/10.1155/2013/813786
Abstract
A 16-year-old Caucasian female presented to the pulmonary clinic for a followup on her asthma. Due to the worsening of allergy-related symptoms, therapy with montelukast 10 mg daily was started and resulted in good relief of the patient’s symptoms. In the nights following initiating therapy with montelukast, the patient’s mother reported daily parasomnias in the form of sleeptalking and sleepwalking. Montelukast was discontinued, and that resulted in absence of the parasomnias. In a second attempt montelukast was reinstituted to control the patient’s symptoms. Parasomnias were immediately reported after resuming therapy. Montelukast was then discontinued indefinitely. Our patient has never had any history of parasomnias, and since the discontinuation of montelukast, parasomnias were never reported again. Parasomnias in the form of sleeptalking or sleepwalking were not previously reported as adverse effects of montelukast. Alternative modalities to treat allergy-related symptoms in patients, who develop parasomnias while receiving montelukast, should be explored.Keywords
This publication has 9 references indexed in Scilit:
- Montelukast for Children With Obstructive Sleep Apnea: A Double-blind, Placebo-Controlled StudyPediatrics, 2012
- Psychiatric adverse drug reactions reported during a 10‐year period in the Swedish pediatric populationPharmacoepidemiology and Drug Safety, 2011
- Antiasthmatic Drugs Targeting the Cysteinyl Leukotriene Receptor 1 Alleviate Central Nervous System Inflammatory Cell Infiltration and Pathogenesis of Experimental Autoimmune EncephalomyelitisThe Journal of Immunology, 2011
- Analysis of behavior-related adverse experiences in clinical trials of montelukastJournal of Allergy and Clinical Immunology, 2009
- Montelukast and psychiatric disorders in childrenPharmacoepidemiology and Drug Safety, 2009
- Leukotriene Pathways and In Vitro Adenotonsillar Cell Proliferation in Children With Obstructive Sleep ApneaChest, 2009
- Leukotriene Modifier Therapy for Mild Sleep-disordered Breathing in ChildrenAmerican Journal of Respiratory and Critical Care Medicine, 2005
- HLA and genetic susceptibility to sleepwalkingMolecular Psychiatry, 2003
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981